Skip to main content
. 2016 Nov 16;2016(11):CD008320. doi: 10.1002/14651858.CD008320.pub3

5.3. Analysis.

5.3

Comparison 5 Rifampicin versus placebo or standard medication, Outcome 3 B) Subgroup analysis by control; SMD: pruritus on different scales; CP participants; cross‐over design.